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Computer-assisted Auscultation as a screening tool for 
Cardiovascular Disease: A cross-sectional study 
1. Synopsis: 
 
Cardiac auscultation remains an important diagnostic tool that provides clinicians 
with a wealth of information regarding patients’ cardiac health. In association with 
clinical features, auscultation gives the physician sufficient information to make 
diagnoses and guide referrals. However the qualitative nature of this practice, 
combined with inadequate training and of late, skills, may limit the ability of 
clinicians to detect and diagnose abnormalities using this method alone. The ability 
to make an accurate diagnosis in particular discerning an innocent murmur from 
one suspicious of pathology has been diminished as this skill is being lost. 
Computer-assisted auscultation is a tool with the potential to make a quantitative 
and objective assessment of cardiac auscultation. The purpose of this study is to 
determine whether the two computer-assisted auscultation methods currently 
available (Sensi® and Cardioscan® respectively) can accurately and with ease, 
identify patients who would qualify for referral for echocardiography for heart 
disease. We envisage that if deemed to be accurate, this tool could be incorporated 
into a tertiary cardiac clinic to aid diagnoses and patient management. 
2.  Research questions: 
 
The proposed research therefore addresses the following research questions: 
• How accurate is computer-assisted auscultation at identifying patients who 
would qualify for referral for echocardiography for heart disease? 
• How does the Sensi® system under development in Cape Town compare 
with the FDA-approved Cardioscan® system? 
• How feasible is the application of computer-assisted auscultation within a 
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3. Background and Rationale: 
 
Ever since the invention of the stethoscope by Laennec in 1816, it has been an 
indispensable aid for the evaluation and management of patients in everyday 
practice. (1) In the hands of skilled practitioners, cardiac auscultation is an 
important diagnostic tool that provides clinicians with a wealth of information 
regarding the cardiac status of a patient. In association with other clinical features, 
auscultation gives the physician sufficient information to make diagnoses and guide 
referrals in the majority of situations. In addition, it connects the physician and the 
patient and constitutes an important part of the ritual of “laying-on of hands”, 
creating a relationship between the physician and the patient. (2)  
Prior to the development of the electrocardiogram (ECG) and more recent imaging 
modalities, the stethoscope was hailed as the most useful investigative tools in the 
cardiologist’s armamentarium and cardiologists of the past were legendary in their 
mastery of the “art” of cardiopulmonary auscultation. (3) 
However the qualitative nature of this practice may limit the ability of clinicians to 
detect and diagnose abnormalities using this method alone. In fact, there is 
decreasing confidence in clinical skills generally and ever-increasing reliance on 
laboratory and diagnostic investigation to solve clinical problems. This is particularly 
so in cardiology with an increased reliance on echocardiography as the ‘new 
stethoscope’. (4) As early as the nineties, a mere 50 years after the invention of 
echocardiography, reports (5, 6) bemoaning the poor auscultatory skills of residents 
was published together with serious concerns regarding inadequate training and 
emphasis on the importance of this skill. (7) In a recent multi-centre study of 
physicians, trainees, students and faculty, it was reported that although the 
sensitivity for systolic murmurs was high (0.84), it carried a very low specificity (0.4) 
and when tested with diastolic murmurs, the sensitivity was in fact no better than 
chance (0.5) (8) In addition to this alarming trend, a conventional stethoscope has 
no ability to record sounds, offer a visual display or transmit sounds to multiple 
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urgent need to explore other methods which can be employed in both the practice 
and teaching of cardiac auscultation. We suggest that computer-assisted 
auscultation may provide this much-needed extension of an old friend. (9) 
3.1. Innocent murmurs 
 
Heart murmurs are common in the general public although many have no clinical 
relevance and are termed “innocent” murmurs. Innocent heart murmurs are sounds 
made by blood circulating through heart chambers and valves or blood vessels near 
the heart. Innocent heart murmurs are more common in children and are 
considered to be harmless. (10) Up to 80% of paediatric patients will have a murmur 
on examination although less than 1% will eventually have a congenital heart 
defect. (11) Praecordial murmurs are also common in young adults, occurring in 
between 29-52% of the general population. (12) Over-referral of patients with 
innocent murmurs for echocardiography is most likely due to the declining expertise 
in cardiac auscultation coupled with increasing reliance on echo-based diagnoses 
but has serious cost and personnel implications.  
Echocardiography is considered to be the gold standard to determine pathological 
cardiac lesions. However the American Heart Association and the American College 
of Cardiology  (AHA/ACC) defines Class 1 recommendations for echocardiography as 
those patients where “clinical features indicate at least a moderate probability that 
a murmur reflects structural heart disease.” (13)The AHA/ACC guidelines strongly 
discourage indiscriminate use of echocardiography as a screening tool due to the 
not insignificant cost and the over-sensitive nature of the results. In current 
resource-restrained times, the appropriate use of technology, skills and personnel is 
an important factor to consider when managing referrals. High-end echo machines 
are exorbitantly expensive and even the decreasing price of portable machines is 
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In 2009, South Africa had twenty four practicing paediatric cardiologists, equally 
distributed between public and private sector units, with a further eight undergoing 
training. (14) This is woefully inadequate for the needs of the country’s children and 
significantly less than the 88 paediatric cardiologists required for the population of 
South Africa. (15)  Although paediatric cardiologists can accurately diagnose an 
innocent murmur with a high degree of sensitivity and specificity  (16), a referral to 
a paediatric cardiologist implies inappropriate use of skilled and scarce personnel. 
Travel to centres where cardiologists are based, with attendant costs and loss of 
income, is costly to patients and parents.  The cost in terms of understanding and 
concern regarding the diagnosis of an innocent murmur is of course difficult to 
estimate as would be the cost of an inaccurate diagnosis of innocent murmur. (17) 
3.2. Referrals for structural heart disease 
 
Although the American Heart Association and the American College of Cardiology 
(AHA/ACC) only recommends that patients with suspected pathological murmurs be 
referred for an echo, (18) patients are still routinely referred to a specialist cardiac 
unit for echocardiography for the evaluation of a murmur.  In a retrospective review 
of 3 460 adult referrals for echocardiogram with the coding ”murmur” as the 
primary reason for the referral, less than 50% had significant valvular disease. (19) 
In another study, approximately two thirds of patients referred to a cardiac centre 
for initial evaluation of heart murmurs had no cardiac abnormalities.(20) In 
paediatrics, although heart murmurs are the most common reason for referral to 
cardiologists, 50-70% of these murmurs are benign. (21). The usefulness of a device 
to aid diagnostic accuracy of referring physicians in determining pathological 
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3.3 Computer-assisted auscultation 
 
In the pre-echocardiography era, the standard acoustic/mechanical stethoscope 
was used as a tool to differentiate not only innocent from pathological murmurs but 
to diagnose cardiac disease consistently and accurately. The advent of 
echocardiography has led to the use of portable machines which have proven to 
have superior sensitivity when compared to the mechanical stethoscope in 
screening for valvular heart disease in asymptomatic children. (22) The yield by 
portable echocardiography is 10 times greater than the mechanical stethoscope, 
leading to the recommendation to abandon the ordinary stethoscope. (4)However, 
the relatively high cost of high-quality portable echocardiography machines and the 
need for trained echocardiographers hamper the adoption of this screening 
modality on a large scale in poor developing countries where valvular heart disease 
remains endemic. It is therefore mandatory to explore other simple, sensitive, 
accessible, and affordable technologies, such as the newly developed 
electronic/digital stethoscope. 
 
The electronic stethoscope may overcome the disadvantages of the mechanical 
stethoscope. The digital stethoscope provides better sound quality and visual 
display of the wave form of the sound. (9) Signals obtained electronically may be 
subjected to objective visual and numerical analysis, transmission to distant sites, 
and storage for medical and research purposes. The quantitative measurement of 
the intensity of the heart sounds and murmurs in the spectral display which is 
recorded simultaneously with the waveform of the sounds allows objective 
classification into normal and abnormal sounds. (23) Of particular importance in 
developing countries, is the cost, time and human resource saving associated with 
its use. The digital stethoscope is a fraction of the cost of a portable 
echocardiography machine, and can be used by nurses or other community health 
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objective, reliable findings that are readily interpretable by practicing clinicians to 
facilitate appropriate referrals to tertiary services.  
The Zargis ® Medical Corporation has FDA clearance for the first product with 
clinically validated indications for uses including the detection of heart murmurs. 
Sensitivity for detection of murmurs increased from 77% to 89% with the use of 
computer-assisted auscultation (CAA) while the referral sensitivity increased from 
87% to 93%. (24)  
The development of a South African hand-held electronic device that can record 
heart sounds using a digital stethoscope, analyze the recordings and aid examiners 
in distinguishing between innocent and pathological murmurs is now at an 
advanced stage.  To date, the hand-held device has a screening sensitivity and 
specificity of 90% and 97% respectively compared to agreement with 
echocardiography. (25)  
Computer-assisted auscultation provides increased objectivity to a traditionally 
subjective, increasingly difficult clinical skill. A diagnostic support tool that could 
increase sensitivity and specificity of the echocardiography referral decisions could 
potentially be highly cost-effective, facilitate a more efficient use of personnel and 
resources and may indeed be the promising technology required to improve the 
referral decisions of primary care physicians. (23) 
4. Hypothesis  
 
Primary: Computer-assisted auscultation is accurate at identifying patients who 
require referral for echocardiography for heart disease in a tertiary cardiac service 
for both adults and children.  
Secondary: The Sensi® unit compares favourably to the FDA- approved Cardioscan® 
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The aims of this study are: 
1. To evaluate the sensitivity and specificity of computer-assisted 
auscultation when compared to echocardiography to identify patients 
who require referral for heart disease. 
2. To evaluate the Sensi® system in comparison with the FDA-approved 
Cardioscan® system. 
3. To describe the feasibility of performing computer-assisted auscultation 
within a tertiary cardiac clinic. 
6. Significance and Implications: 
 
Computer-assisted auscultation is a tool with the potential to make a quantitative 
and objective assessment of cardiac auscultation. Incorporating CAA into clinical 
practice could potentially allow for appropriate additional information in terms of 
structural heart disease and may well serve as a clinician’s tool especially in 
resource-poor settings allowing for easier diagnosis.  
We envisage that this will improve the quality of patient care and reduce the costs 
associated with inappropriate referral and the use of more expensive technologies. 
In addition it would add a further dimension to patient management in terms of the 
ability to store audio files in patients’ records and providing a new platform for 
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7.1 Study design  
 
In this cross-sectional study, eighty consecutive patients referred for assessment to 
either the Groote Schuur Hospital (GSH) cardiac clinic or the cardiologists at Red 
Cross War Memorial Children’s Hospital (RCWMCH) will be recruited for the study. 
All patients will be enrolled by a qualified nursing sister and once consent has been 
given, enrolled in the study. Participants will undergo an examination using both of 
the computer-assisted auscultation methods with results recorded in audio files and 
noted in unique-numbers case record forms. Patients will thereafter undergo the 
standard examination as per standard of care which will include in each case, an 
echocardiogram and clinical examination. At the end of the examination session, 
the nurse will complete a case record form detailing the referral request, findings of 
physicians, the echocardiogram findings and the results of the audio files of the two 
auscultation methods. It is possible that in certain cases the physicians’ 
examinations and echocardiogram will occur before the auscultation, as the 
auscultation will in no way influence the standard procedures occurring at each 
institution. The findings of referring physicians will not be entered into the 
computer at the time of auscultation, hence not influencing the outcome of the 
computer assessment. The results of the computer’s findings will not be revealed to 
any treating physicians.  
7.2 Characteristics of the study population 
 
Setting: Patients are referred to RCWMCH and GSH cardiac clinics as the 2 of the 3 
major referral hospitals in the Western Cape. These patients are referred for both 
structural and functional concerns and referrals are from physicians as well as GPs 
or primary health care practitioners. These are the two largest referral centres in 











 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 
14 | P a g e  
 
7.3 Recruitment and enrollment  
 
GSH: Patients referred for echocardiogram are referred directly to the echo clinic. 
These patients will be approached by our nursing sister and screened for possible 
participation. This will occur prior to or in some cases after the echocardiogram has 
been performed and will not influence the waiting time of the participants.  The 
research nurse will ensure that patients do not miss their space in the queue. The 
entire process should take less than 15 minutes to complete.  
RCWMCH: Patients referred to paediatric cardiology are referred in one of 2 ways: 
either directly to the senior registrar on call or to the cardiac clinic. On the days that 
the nursing sister is on site on clinic days, she will liaise with the sister running the 
clinic and identify all new referrals and approach them to participate in the study, 
again taking care not to lose any places in the queue. Patients will be examined in a 
separate cubicle and thereafter return to the queue for standard care. The names of 
patients referred directly to the senior registrar will be given to the study sister who 
will then approach the patient and his/her legal guardian for consent before 
enrolling a patient in the study. These patients are normally in-patients and will be 
seen by cardiologist when time allows- hence these patients will not be 
inconvenienced by the study. Auscultation in these patients can occur at the 
bedside providing environmental conditions are appropriate.  
7.4 Inclusion and exclusion criteria:  
 
80 consecutive patients from the two institutions will be recruited. Recruitment will 
occur on the days when the trained sister is on site only. All stable patients outside 
of the newborn period will be screened for possible inclusion. Patients over the age 
of 18 will approached to give consent; consent will be taken from the legal 
guardians of children under the age of 18 as well as assent from those over the age 
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approached for possible participation in the study. If an interpreter is available, 
patients speaking only Xhosa will also be approached.   
 
Patients who have been operated upon or those who are unable to provide or those 
who refuse informed consent will be excluded from participation. Patient deemed 
too unstable will also be excluded from the study. 
7.5 Research procedures and data collection methods 
 
 Patients will be enrolled and using designated case record forms (CRF) data will be 
captured regarding baseline demographic data, reason for referral, clinical, echo 
findings followed by the findings of the two systems.  
 Data collection method: 
Patients will be examined in a quiet area in either the cardiac clinic or at the 
bedside. When using the Zargis® system, the patient is auscultated using a 
Bluetooth Littman® electronic stethoscope. The heart sounds and if present 
murmurs are transmitted to a receiving computer loaded with the Cardioscan 
®software.  The heart sounds are recorded at 4 positions for 20 seconds each. The 
software will analyse the recording for up to one minute and the display the 
findings as abnormal or normal.  Computer-assisted auscultation findings will be 
stored on a password-controlled netbook in .zac files for the Zargis® system. These 
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Figure 1. Areas of Auscultation  Figure 2. Zargis ®user interface. 
 
With the Sensi® system, 3 ECG electrodes will be placed upon the chest. Following 
this, recordings at the same four precordial positions will be made. Again the 
recordings will take 20-30 seconds per site and up to one minute to analyse. The 
results are displayed on the computer and converted into .pdf files while the audio 
files are saved as .wmv files.  
As one can see from Fig 2 above, the records in the four positions will be displayed 
as would be any murmurs detected together with the analysis decision. The nursing 
sister conducting the study will undergo extensive training on the operation of both 
systems; equipment will be kept in a secure location and protected to ensure that 
neither the stethoscopes nor the laptop are damaged.  
7.6 Data safety and monitoring 
  
1. Data: The research sister will keep all recordings in a data base on a 
computer provided by the principal investigator. All audio files can only be accessed 
via a password. The Bluetooth stethoscope itself can only be utilized if the matching 
computer and passwords are connected. The associated patient consent and clinical 
forms will also be kept by the research sister and then transferred and filed in a 
locked facility at Groote Schuur Hospital. Keys are kept by the sister and the 
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2. The Principal investigator will collect the recordings and forms on a 
predefined time from the locked facility and enter it onto an additional data base. 
This will be done on regular intervals and will serve as a back-up and will also be 
kept in a locked facility. 
 
3. The sister will collect the echocardiogram reports from the cardiac clinic at 
Groote Schuur and Red Cross Children’s Hospitals. If any doubts regarding diagnosis 
exist, she will confirm the diagnosis with the cardiologist on call without revealing 
the findings of the computer-assisted auscultation.  
 
4. The Principal investigator will evaluate all recordings and forms before 
approving it as suitable for use and included it in the final analysis. 
 
5. Finally a study monitor will review the entire process before commencing 
the study and again at the end of the study to ensure quality assurance and control. 
This monitor will be approached by the P.I. to perform this task.  
7.7 Data analysis  
 
Data will be entered into an Excel spreadsheet and analysed using STATA® version 
11, Stata Corporation, 4905 Lakeway Drive, College Station, Texas 77845 USA. The 
original paper based questionnaire will be entered onto a database. All original 
questionnaires will also be stored for validation purposes. A sample size of 80 
patients was calculated to achieve <10% confidence intervals around an estimated 
sensitivity of 90% for either computer-assisted stethoscope.   
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Table 1. Variables collected
Variable Name Scale of Measurement Variable Name Scale of Measurement
Age in months/years Numerical Continuous Echo category
GSH or RXH Categorical Binary 0= Normal, no heart disease
Ward vs. Outpatient referral Categorical Binary 1= Acyanostic congenital
Reason for referral Text field 2+ Cysnotaic congentital
CAA completed 3= Valvular heart disease
0=Both completed 4=Cardiomyopathies
1=One only 5= Other.
Clinical Diagnosis Categorical Nominal S quality
Findings on Cardioscan ® 0= Excellent
1=Abnormal 1= Some problems but protocol complete
2=Normal 2= Bad, protocol not completed
Findings on Sensi® system S confidence Numerical continuous
1=Abnormal C quality
2=Normal 0= Excellent
Echocardiogram diagnosis Categorical Nominal 1= Problems but protocol compl ted
Standard Auscultation Categorical Nominal 2= Bad, protocol not completed
Murmur class S _prot
0= normal Heart Sounds,, no murmur 0=Protocol not completed
1= 1/6 Ejection Systolic Murmur 1=Protocol completed
2= 2/6 Ejection systolic murmur C_prot
3= 3/6 Haolsystolic murmur 0=Protocol not completed
4=2/6 midsystolic murmur 1=Protocol completed 
5=2/6 Diastolic murmur Echo_diagnosis
6=2/6 Continous murmur 0=Normal
1=Abnormal
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The findings of the computer analysis will be recorded as normal or abnormal. The 
echocardiography findings will be correlated with the findings of the computer assisted 
method and the sensitivity and specificity to detect heart disease requiring echo will be 
reported upon. The results will also be stratified in terms of the two hospitals and age 
categories. The findings in adults and children will be analysed using the Mantel-
Haenszel Test for heterogeneity. Analyses will be performed on the subcategories of 
pathologies. The 2 methods will be compared and the feasibility in terms of conducting 
the study will be assessed.  
8. Expected benefits to individual participants and potential societal 
benefits 
 
There will be no immediate benefits to any of the patients involved in the study. 
Computer-assisted auscultation potentially could improve the diagnostic accuracy of 
standard auscultation; provide objective and repeatable findings and aid in the 
teaching and training of clinicians and students in standard auscultation. Potentially 
this could also be a cost-effective device that could be widely used by primary care 
physicians, community nurses or even health care workers and as such be an ideal tool 
for us in resource-poor settings. In addition many murmurs in childhood are termed 
innocent as they do not represent any pathology and in fact, should not be subject to 
unnecessary referrals.  
9. Consent and assent 
 
A screening log will be held of all potential participants. All participants that are eligible 
for inclusion will then be approached and given the opportunity to enter the study. 
Recruitment will only be done at the cardiac clinics and through cardiology registrars 
on call. Informed consent and assent will be taken by the research sister.  
As auscultation is a common and widely accepted standard of care, we do not envisage 
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we will explain that the computer-generated findings will not be transmitted to the 
physicians and that the results of the computer findings will have no influence on 
current care but is focused on testing new technology and influencing future 
approaches. As the entire process takes less than 15 minutes (including consent 
process) we foresee that it will be acceptable to all patients. 
10. Description of risks and benefits 
 
As auscultation is a common and widely accepted standard of care, we do not envisage 
any additional risks for patients or their carers. Auscultation will be performed using a 
digital stethoscope that connects to a computer-programme using a Bluetooth device. 
The Sensi® system has 3 electrocardiogram (ECG) electrodes in addition to the device 
which is applied to the chest.  
Both the Cardioscan® and Sensi® systems take 20 seconds per recording area (4 
precordial positions) and then an additional minute to analyse.  
The auscultation will take place in a standard clinic room within the cardiac clinic or at 
the bedside when appropriate. Any patients deemed in any way unstable or ill will be 
excluded from the study and referred for immediate medical attention if required. 
11. Privacy and confidentiality 
 
Privacy and confidentiality will be maintained at all times. All examinations and 
screening procedures will occur in private, all data will be recorded on case record 
forms, maintaining patient confidentiality, revealed only to the study team. The 
research sister is GCP-trained and NIH certified. Audio records will be stored on a 
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12. Reimbursement for participation 
 
As patients will not be inconvenienced nor be required to travel, we will not offer any 
compensation. 
 
13. Emergency care and insurance for research-related injuries 
 
Any critically ill patients or patients in the newborn period will be excluded. Children 
are often referred for structural heart disease and as the incidence of congenital heart 
lesions at birth is just under 1% (26), this is an important gr up to include in our study. 
Possible risks related to examination are felt to be minimal.. Patients are covered by 
the University of Cape Town no-fault insurance. 
14. Significance 
 
Computer-assisted auscultation potentially could improve the diagnostic accuracy of 
standard auscultation; provide objective and repeatable findings and aid in the 
teaching and training of clinicians and students in standard auscultation. Potentially 
this could also be a cost-effective device that could be widely used by primary care 
physicians, community nurses or even health care workers and as such be an ideal tool 
for us in resource-poor settings. In addition many murmurs in childhood are termed 




Although echocardiography is a sensitive tool for detecting structural heart disease, it is 
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have decreased markedly of late and this has led to an over-reliance on 
echocardiography and hence increased referrals to tertiary centres for benign 
conditions such as innocent murmurs.   
We believe that computer-assisted auscultation method is a feasible, effective and 
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17.1 Consent Form ( English) 
Participant Information Leaflet and consent form: Adults 
Computer-Assisted Auscultation 
 
Title: Is computer-assisted auscultation accurate at identifying heart disease 
requiring referral for echocardiography in a tertiary cardiac clinic? 
 




Investigator:   
 
Dr Liesl Zühlke  









This is a very important form. You are being invited to take part in a research project. 
Please take some time to read the information presented here, which will explain the 
details of this project. Please ask the study staff or doctor any questions about any part of 
this project that you do not fully understand.  
• It is very important that you are fully satisfied and clearly understand what this 
research entails and you could be involved.  
• Your participation is entirely voluntary and you are free to decline to participate. 
If you say no, this will not affect you or negatively in any way whatsoever.  
• You are also free to withdraw from the study at any point, even if you do initially 
agree to let take part. 
 
This study has been approved by the Faculty of Health Sciences Human Ethics 
Committee no: 359/2010 and will be conducted according to the ethical guidelines and 
principles of the International Declaration of Helsinki, South African Guidelines for 
Good Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines for 
Research. This is an important form. Before you make a decision to take part in the 
study, it is important that you understand why the project is being conducted and what it 
will involve. If you have any questions feel free to ask your doctor. Your signature on 
this form means that you wish to take part in this study. 
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The aim of this project is to determine whether a computer can tell which heart sounds 
and murmurs will need specialist attention. To achieve this, two special stethoscopes 
will be used to record your hearts sounds and this will be sent to a recorder/computer 
where the heart sound data will be analysed. This will only take a few minutes to do. 
You will still be seen by the doctor and have whatever tests he/she feels are necessary. 
The doctor will not see the results of the computer’s opinion. 
  
Why have I been invited to participate? 
You have been chosen for this study since they have been referred to these heart 
clinic/heart specialists. Once you consent to participate, our research staff will collect 
some information about you and use the special stethoscopes to listen to your heart and 
record the heart sounds. No other tests will be performed for this study. You will then 
have your normal examination by the doctors. We will ensure that you do not lose your 
place in the queue.   
Are there benefits to taking part in this study? 
There are no direct benefits to you by participating in the study. By participating in the 
study you will be providing us with valuable information regarding a possible future test 
that can help doctors and patients. This may ultimately lead to improvements in care of 
patients like you in the future. 
What are the risks in participating in the study? 
There are no risks to you in participating in this study. All the equipment is approved, a 
qualified nursing sister will perform the test and everything will be done at this clinic/or 
at the bedside. 
Do I incur any costs due to my participation in the study? 
No, you will not incur any extra costs as a result of participating in the study. You will 
not be reimbursed for participating in the study. 
Voluntary Participation 
It is entirely your decision to participate in the study. If you want to discontinue from the 
study at any point of time you are free to leave without stating any reason.  Your 
withdrawal will not affect your treatment at this hospital. Irrespective of your decision to 
participate in the study, you will still receive the standard treatment for your illness. 
What about confidentiality? 
The investigators will ensure that personal information obtained from you for the study 
will remain confidential throughout the study period. When the results are published in a 
medical journal, your name and other details will not be disclosed. 
What will happen in the unlikely event of me getting injured in any way, as a direct 
result of taking part in this research study? 
A full investigation, that includes your involvement, will be launched and you will be 
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Thank you for taking time to read this information sheet.  
If you have any study related queries you can contact, Dr. L.Zühlke, Paediatric 
Cardiologist  Department of Paediatric Cardiology, Red Cross Children’s Hospital at 
021- 4047676.                                     
If you wish to take part in this study, please sign and date the consent form given to you. 
You will be given a copy of the information sheet and your signed consent form.  
Declaration by patient 
 
By signing below, I (name of patient)………………………………………………………….. 
 
agree to take part in a research study entitled: Computer-Assisted Auscultation: 
 Is computer-assisted auscultation accurate at identifying heart disease requiring 
referral for echocardiography in a tertiary cardiac clinic? 
 
 
I declare that: 
• I have read or had read to me this information and consent form and that it is 
written in a language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
• I may choose to withdraw   from the study at any time and I will not be 
penalised or prejudiced in any way. 
• I may be asked to leave the study before it has finished if the study doctor or 
Study nurse feels it is in my best interests. 
 




Declaration by investigator 
X
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I (name) ............................................................................ declare that: 
_ I explained the information in this document to 
.................................................................... 
_ I encouraged him/her to ask questions and took adequate time to answer them. 
_ I am satisfied that he/she adequately understand all aspects of the research, as 
discussed 
above 
_ I did/did not use a interpreter (if a interpreter is used, then the interpreter must sign the 
declaration below). 
 











• I assisted the investigator (name) ......................................................... to explain 
the information in this document to (name of participant) 
.......................................................... using the language of Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
 
3. IF THE PARENT/GUARDIAN CANNOT READ THE FORM THEMSELVES, A WITNESS 
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I was present while the informed consent document with benefits, risks and 
procedures were read to the parent/guardian and the participant. The parent/guardian 
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17.2 Consent Form (Afrikaans) 
Deelnemer Informasieblad en toestemmingsvorm: Kinders 
Vir gebruik deur ouers/wettige voog 
 
Rekenaar-Geassisteerde Gehoor van hartklanke: 
 
Titel: Is rekenaar-geassisteerde gehoor van hartklanke akkuraat daarin, om 
hartprobleme wat verwysing vir eggokardiogram na ‘n tersiêre hartkliniek 
vereis, te identifiseer? 
 
FHS HEC  Nr: 
 
 
Hoof Ondersoeker:   
 
Dr Liesl Zühlke  





Rooikruis Kinderhospitaal, Mowbray 021 6585366 





Hierdie is ‘n baie belangrike vorm. U kind (of wyk, indien toepaslik), word gevra om 
deel te neem aan ‘n navorsingsprojek. Die inligting wat hierdie vorm bevat, beskryf die 
inhoud van die projek. Ruim asseblief tyd in om dit te lees. Voel vry om enige vrae oor 
enige deel van hierdie projek wat u nie heeltemal verstaan nie aan die studie personeel of 
dokter te rig.  
• Dit is baie belangrik dat u heeltemal tevrede is en duidelik verstaan wat hierdie 
navorsing behels en hoe u kind daarby betrokke kan wees.  
• U kind se deelname is heeltemal vrywillig en u beskik oor die reg om deelname 
te weier.  Indien u nee sou sê, sal dit nie u of u kind op enige wyse benadeel nie.  
• U is ook vry om hom/haar ten enige stadium van die projek te onttrek, selfs al het 
u aanvanklik ingestem om hom/haar te laat deelneem. 
 
Hierdie studie is goedgekeur deur die Fakulteit van Gesondheidswetenskappe Menslike 
Etiese Kommittee nr: en sal uitgevoer word volgens die etiese regulasies en beginsels 
van die Internasionale Verklaring van Helsinki, Suid-Afrikaanse Riglyne vir Goeie 
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Dit is ‘n belangrike vorm. Voor u besluit om deel te neem, is dit belangrik dat u verstaan 
hoekom hierdie projek uitgevoer word en wat dit behels. Voel vry om enige vrae aan u 
dokter te rig. Jou handtekening op hierdie vorm sal beteken dat jy kies om deel te neem 
aan die studie. 
 
Waaroor gaan hierdie navorsingstudie? 
Die doel van hierdie projek is om te bepaal of ‘n rekenaar kan aandui watter hartklanke 
en geruise die aandag van ‘n spesialis nodig het. Om dit reg te kry, sal twee spesiale 
stetoskope gebruik word om u kind se hartklanke op te neem. Die opname sal na ‘n 
opnemer/rekenaar gestuur word waarop die hartklank data geanaliseer gaan word. Dit 
sal slegs ‘n paar minute neem om te doen. U sal steeds deur die dokter gesien word en 
alle toetse ondergaan wat hy/sy voel nodig is. Die dokter sal nie die uitslag van die 
rekenaar-opinie sien nie. Hoekom is my kind gevra om deel te neem? 
Jou kind is gekies vir hierdie studie omdat hy/sy verwys is na hierdie hartkliniek/hart 
spesialis. Sodra u toestemming gee vir u kind om deel te neem, sal ons navorsing 
personeel sekere inligting oor u kind insamel en die spesiale stetoskope gebruik om na u 
kind se hart te luister en die hartklanke op te neem. Geen ander toetse sal vir hierdie 
studie uitgevoer word nie. Jy sal daarna jou normale ondersoek by die dokters 
ondergaan. Ons sal seker maak dat u nie u plek in die ry verloor nie.   
Is daar enige voordeel daarin om deel te neem aan die studie? 
Daar is geen direkte voordele verbonde aan u of u kind se deelname aan die studie nie. 
Deur deel te neem aan die studie sal u ons van waardevolle inligting voorsien aangaande 
‘n moontlike toekomstige toets wat dokters en pasiënte kan help. Dit mag uiteindelik lei 
tot verbeteringe in die toekomstige sorg van pasiënte, soos uself. 
Wat is die risiko’s daaraan verbonde om aan die studie deel te neem? 
Deelname hou geen risiko’s vir u of u kind in nie. Al die toerusting is goedgekeur, ‘n 
gekwalifiseerde suster sal die toets uitvoer en alles sal gedoen word by hierdie kliniek/ 
langs die bed. 
Sal my deelname aan die studie my enigeiets kos? 
Nee, u sal nie enige ekstra uitgawes hê as ‘n resultaat van u deelname aan die studie nie. 
U sal nie finansiële vergoeding ontvang vir deelname aan die studie nie. 
Vrywillige Deelname 
Dit is heeltemal u eie besluit om deel te neem aan die studie. Indien u op enige stadium 
van die studie wil onttrek, is u vry om so te doen, sonder om enige rede te gee. Jou 
onttrekking van die studie sal nie u behandeling by hierdie Hospitaal affekteer nie. U sal 
steeds standard behandeling vir u kondisie ontvang, ongeag u besluit om deel te neem 
aan die studie of nie. 
Wat van konfidensialiteit? 
Die ondersoekers sal u verseker dat alle persoonlike inligting wat van u verkry is, 
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gepubliseer word in ‘n mediese joernaal, sal u naam en ander besonderhede nie bekend 
gemaak word nie. 
Wat sal gebeur ingeval die onwaarskynlike gebeur en u kind beseer word as ‘n 
direkte resultaat van deelname aan die navorsingstudie? 
‘n Volledige ondersoek, wat u betrokkenheid insluit sal volg, en u sal vergoed word 
indien enige nalatigheid die oorsaak was van die besering. 
 
Dankie vir die tyd wat u afgestaan het om die inligtingsblad te lees.  
Indien u enige studie-verwante vrae het, kan u Dr. L.Zühlke, Pediatriese Kardioloog by 
die   Departement van Pediatriese Kardiologie, Rooikruis Kinderhospitaal kontak by 
021- 4047676.                                     
Indien u kies om deel te neem aan die studie, kan u asseblief die toestemmingsvorm wat 
aan u gegee word teken, asook die datum aandui. U sal ’n afskrif van die inligtingsblad 
en die getekende toestemmingsvorm gegee ontvang.  
Verklaring deur ouer/wettige voog 
 
Deur hieronder te teken, stem ek (naam van ouer/wettige 
voog)…………………………………………….. 
 
in om my kind (name van kind) ......................................................................... wat  
 
……………………..jaar oud is, te laat deel neem aan die navorsingstudie getitel: 
Rekenaar-geassisteerde Gehoor van hartklanke:  Is rekenaar-geassisteerde gehoor 
van hartklanke akkuraat daarin, om hartprobleme wat verwysing vir 
eggokardiogram na ‘n tersiêre hartkliniek vereis, te identifiseer? 
 
 
Ek verklaar dat: 
• Ek hierdie inligting en toestemmingsvorm gelees het, of dat dit aan my gelees 
is en dat dit geskryf is in ‘n taal waarin ek vlot is en waarmee ek gemaklik 
voel.  
• Indien my kind ouer as 7 jaar is, hy/sy moet instem om deel te neem aan die 
studie en dat sy/haar INSTEMMING EN BEGRIP aangedui moet word op die 
vorm. 
• Ek het die geleentheid gehad het om vrae te vra en al my vrae is voldoende 
beantwoord.  
• Ek verstaan dat my deelname aan die studie vrywillig is en dat daar nie druk 
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• Ek mag kies om my kind op enige stadium te onttrek en dat my kind op geen 
wyse gepenaliseer of bevooroordeel sal word nie. 
• My kind gevra mag word om die studie te verlaat voor dit klaar is, indien die 




Geteken te (plek).................................................. op 
(datum).........................................2010. 
 
Verklaring deur ondersoeker 
Ek (name) ............................................................................ verklaar dat: 
_ Ek die informasie in die dokument aan ................................................................ 
verduidelik het 
_ Ek hom/haar aangemoedig het om vrae te vra en dat ek genoeg tyd ingeruim het om dit 
te beantwoord. 
_ Ek tevrede is dat hy/sy all die aspekte van die navorsing voldoende verstaan, soos bo 
bespreek 
_ Ek het ‘n tolk geberuik / nie (indien ‘n tolk gebruik is, moet die tolk die verklaring 
hieronder teken). 
 






Verklaring van tolk 
 
X
Signature of parent/legal guardian
X
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Ek (name) .........................................................................verklaar dat: 
• Ek die ondersoeker (name) ......................................................... geassisteer het deur die 
informasie in hierdie dokument aan (name van die ouer/wettige voog) 
..........................................................te verduidelik  in die taal van Afrikaans/Xhosa. 
• Ons het hom/haar aangemoedig om vrae te vra en het genoeg tyd geneem om dit te 
beantwoord. 
• Ek het die feite aan my voorgelê korrek vertolk. 
• Ek is tevrede dat die ouer/wettige voog die inhoud van hierdie ingeligte-toestemming 
dokument volkome verstaan en dat sy/haar vrae bevredigend beantwoord is. 
 




3. INDIEN DIE OUER/VOOG NIE HIERDIE VORM SELF KAN LEES NIE, MOET ‘N 
GETUIE HIER TEKEN: 
 
 
Ek was teenwoordig terwyl die ingeligte-toestemming dokument insluitend voordele, 
risiko’s en prosedures aan die ouer/voog en die deelnemer gelees is. Die ouer/voog het 
vrylik en vrywilliglik ingestem om sy/haar dogter/seun te laat deelneem aan die 
navorsing. 
 
Geteken te (plek) ..................................................... op (datum) ......................................... 
2010. 
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Ons is dokters en susters van Rooikruis Kinderhospitaal, Groote Schuur Hospitaal en 
Tygerberg 
Hospitaal en ons is besig om ‘n studie te doen oor die harte van kinders. Ons wil graag 
sien of ‘n rekenaar kan sien watter hartklanke spesiale dokters nodig het om meer 
toetse te doen. Ons kyk na kinders wat na hierdie kliniek gestuur is. Ons wil graag vra of 
ons na jou hart kan luister met hierdie spesiale stetoskope. Dit sal nie seer wees nie en 
is baie vinnig. 
Indien jy ja sê om deel te neem aan die studie, sal jy dokters help om te weet hoe om 
ander kinders beter te behandel in die toekoms. Jy mag sê dat jy nie in die studie wil 
wees nie. Niemand sal vir jou kwaad wees as jy nee sê nie.  
Voor jy besluit, kan jy vir ons vrae vra.  As jy in die studie wil wees, moet jy jou name op 













Printed name Signature Date
X
Printed name Signature Date
X










 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 
38 | P a g e  
 






  Hosp eg RXH, GSH    
Informed consent: yes.. 
   
Informed assent: yes.. 
     
 
 
Age in Months: 
Age in years: 
Reason for referral to clinic/cardiologist:………………………………………………………... 
d d m m 2 0 y y 
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Yes   
NO 
 
Conclusion: normal   abnormal 
 
Attached .zac file 
 
Diacoustic Sensi : 
 
Completed Protocol: 







Conclusion: normal   abnormal 
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Position: eg MO/Reg/GP/Cardiologist 
 





Position: eg tech/Reg/GP/Cardiologist 
 

















 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 
41 | P a g e  
 











 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 




1. Introduction ....................................................................................................... 43 
2. Background ........................................................................................................ 43 
3. The Needs ........................................................................................................... 44 
3.1 Innocent murmurs ........................................................................................... 44 
3.2 Class I recommendations for echo ................................................................... 45 
3.3 The lack of sufficiently qualified practitioners ................................................. 46 
3.4 The range of auditory sounds .......................................................................... 46 
3.5 The waning art of auscultation ........................................................................ 48 
3.6 Referrals for structural heart disease .............................................................. 49 
3.7 Portable echocardiography versus auscultation.............................................. 49 
3.8 Digital stethoscopes: development and properties ......................................... 50 
3.9 Clinical opportunities ....................................................................................... 51 
3.10 Opportunities for future research ................................................................. 52 
4. Challenges and further development ................................................................ 52 
5. Conclusion .......................................................................................................... 53 












 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 




For decades, cardiac auscultation has been an important diagnostic modality, providing 
skilled clinicians with important information regarding patients’ cardiac health. In 
association with other clinical features, auscultation gives the physician sufficient 
information to make diagnoses and guide referrals. In addition, it is simple, cheap and 
accessible. However, this practice remains qualitative and highly subjective. The ability 
to discern an innocent murmur from one suspicious of pathology is rapidly diminishing. 
The time has come to reconsider the way we use auscultation and bring it into the 
current technological era. The development of digital stethoscopes and the additional 
analysis software elevates the simple stethoscope into a tool with the potential to 
make cardiac auscultation a quantitative and objective assessment.  
2. Background 
 
Ever since the invention of the stethoscope by Laennec in 1816, it has been an 
indispensable aid for the evaluation and management of patients in everyday practice. 
(1) In the hands of skilled practitioners, cardiac auscultation is an important diagnostic 
tool, allowing clinicians to diagnose cardiac disease consistently and accurately. In 
addition, it connects th  physician and the patient and constitutes an important part of 
the ritual of ‘laying-on of hands’, creating a relationship between the physician and the 
patient. (2) Prior to the development of the electrocardiogram (ECG) and more recent 
imaging modalities, the stethoscope was hailed as the most useful investigative tools in 
the cardiologist’s armamentarium, and cardiologists of the past were legendary in their 
mastery of the ‘art’ of cardiopulmonary auscultation. (3, 4) 
However, of late, there is decreasing confidence in clinical skills generally and ever-
increasing reliance on laboratory and diagnostic investigation to solve clinical problems. 
This is particularly so in cardiology with an increased reliance on echocardiography as 










 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 
44 | P a g e  
 
invention of echocardiography, reports bemoaning the poor auscultatory skills of 
residents were published (6, 7) together with serious concerns regarding inadequate 
training and emphasis on the importance of this skill. (8) In a multi-centre study of 
physicians, trainees and faculty, it was reported that although the sensitivity for systolic 
murmurs was high (0.84), it carried a very low specificity (0.35), and when tested with 
diastolic murmurs, the sensitivity was in fact no better than chance (0.49). (9)  
In addition to this alarming trend, a conventional stethoscope has no ability to record 
sounds, offer a visual display or transmit sounds to multiple listeners, all critical to the 
effective teaching of auscultation. (6) There is thus an urgent need to explore other 
methods which can be employed in both the practice and teaching of cardiac 
auscultation. (10) 
3. The Needs 
3.1 Innocent murmurs  
 
The ability to differentiate between an innocent and a pathological murmur is a 
fundamental skill for primary health care physicians. Innocent heart murmurs, made by 
blood circulating through heart chambers and valves or blood vessels near the heart, 
are more common in children and are considered to be harmless. (11) Up to 80% of 
paediatric patients will have a murmur on examination, although less than 1% will 
eventually have a congenital heart defect. (12) Precordial murmurs are also common in 
young adults, occurring in between 29-52% of the general population. (13) 
Differentiating between an innocent and a pathological murmur requires considerable 
skill and confidence as well as intimate knowledge of the manoeuvres required to 
confirm the innocent nature of the murmur, coupled with the appropriate physical 
examination. (14) However, due to frequently limited auscultation experience and 
decreasing confidence in clinical skills, this skill is being lost. (15) In fact, in a study by 
Gaskin, the innocent murmur was the most frequently misdiagnosed lesion when 
testing auscultatory skills in paediatric residents. (16) Over-referral of patients with 
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implications. The cost in terms of understanding and concern regarding the diagnosis of 
an innocent murmur is difficult to estimate, as would be the cost of an inaccurate 
diagnosis of an innocent murmur. (17) The diagnosis of an innocent murmur by a 
paediatric cardiologist has been shown to result in parental acceptance of the absence 
of disease and therefore led to children being treated normally. (18) This may be due to 
the weight given to a sub-specialist opinion, as opposed to that of a general physician 
or paediatrician. However, this fundamental differentiation between an innocent and a 
pathologic murmur should be within the skill set of any generalist. (19) 
3.2 Class I recommendations for echo  
 
Echocardiography is considered to be the gold standard to determine pathological 
cardiac lesions. Yet, the guidelines by the American Heart Association and the American 
College of Cardiology (AHA/ACC) strongly discourage indiscriminate use of 
echocardiography as a screening tool due to the cost and the over-sensitive nature of 
the results. The AHA/ACC defines Class 1 recommendations for echocardiography as 
those patients where ‘clinical features indicate at least a moderate probability that a 
murmur reflects structural heart disease’. (20)A study evaluating the ACC/AHA 
echocardiographic guidelines demonstrated a 100% negative predictive value for 
innocent murmurs detected by experienced cardiology staff. In this study, an approach 
following the guidelines on the use of echocardiography would have prevented 58% of 
echocardiograms, at a not insignificant cost. (21) In addition, Class II a 
recommendations are defined as conditions for which there is conflicting evidence 
and/or a divergence of opinion about the usefulness and efficacy of echocardiography. 
Finally, Class III recommendations speak to conditions for which there is evidence 
and/or general agreement that echocardiography is not useful and may in some cases 
be harmful. In current resource-restrained times and low- or middle-income countries, 
the appropriate use of technology, skills and personnel is an important factor to 
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and even the decreasing price of portable machines is difficult to justify in developing 
countries. 
 
3.3 The lack of sufficiently qualified practitioners 
 
In 2009, South Africa had only 24 practicing paediatric cardiologists (22),  significantly 
less than the 88 paediatric cardiologists required for the children of South Africa. (23)  
This is woefully inadequate for the needs of the country’s 18.7 million children. 
Although paediatric cardiologists can accurately diagnose an innocent murmur with a 
high degree of sensitivity and specificity (24), a referral to a paediatric cardiologist for 
an innocent murmur implies inappropriate use of skilled and scarce personnel as well 
as the attendant costs related to travel and loss of income. A dearth of practicing 
physicians is a problem shared by many low- and middle-income countries with access 
to sub-specialists or even specialists confined to larger centres and capital cities only. 
(25)  
3.4 The range of auditory sounds  
 
Standard auscultation, though cheap and accessible, is highly subjective, relies heavily 
on the skill and experience of the operator, and is subject to inherent human acoustic 
abilities. In addition, different stethoscopes also have different abilities, and electronic 
or digital stethoscopes have the added benefits of being able to increase the sound and 
amplify certain elements. The range at which we hear heart sounds and murmurs is 
within the range of frequencies detectable by the human ear. The human ear is capable 
of hearing frequencies within the range of 20-20,000 Hz during childhood and 50-
12,000 Hz in adulthood. (26) The human ear performs best in the range 1-2 kHz while 
below 30Hz or above 18 Hz, the sensitivity falls effectively to zero. It is thus not 
surprising that some physicians encounter problems when identifying some murmurs 
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that low-frequency murmurs such as the diastolic murmur of mitral stenosis in the 
range 20-70Hz are often missed by physicians.  
 
Fig.1 Relative Frequency ranges (Taken from Selig M. Am Heart Journal. 1993) (27) 
 
Secondly, the ear has great difficulty in detecting certain sounds in the presence of 
other loud sounds or high ambient noise. Hospital wards are notorious for having high 
levels of ambient noise and monitors with loud alarms. Thirdly, the auscultator needs 
intensive training to achieve the ability to actively listen, selectively discern and lock on 
pertinent information while blocking out extraneous noise such as breath sounds. 
Fourthly, the human ear also has great difficulty in discriminating time intervals. The 
smallest interval that can be confidently discriminated is 20 msec. It is hardly surprising, 
therefore, that the awareness of the splitting of the second sound, occurring within 30 
msec, may be a difficult new skill to acquire. Finally, some colleagues (elderly physicians 
or younger colleagues who may have listened to loud music for prolonged periods) may 
simply not possess the acoustic ability to hear high-frequency sounds such as the soft 
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instrument, skilled use is anything but simple. Proficiency requires good hearing, the 
ability to concentrate and discriminate, a quiet environment and a sense of auditory 
pattern recognition. It is clear, therefore, that standard auscultation is highly 
subjective, clearly dependent on many variables, lacks sufficient sensitivity and is 
limited by inherent human acoustic abilities. 
3.5 The waning art of auscultation 
 
The lack of ability of today’s physicians to competently and confidently diagnose a 
pathological murmur and reliably discern this from an innocent murmur has been 
blamed on many things, from the increasing reliance on technology to the lack of 
experienced teachers, coupled with decreased bedside teaching. Despite the fact that 
directors of medical school programs considered auscultation an important clinical skill 
worthy of additional training, only 27.1% of internal medicine and 37.1% of cardiology 
programs offered any structured teaching of auscultation. (6)Of more concern in this 
study, was the findings that the accuracy levels, when tested on 12 pre-recorded 
cardiac events, was only 0% to 56.2% for cardiology fellows (median 21.9%) and 2% to 
36.8% for medical residents (median 19.3%). Of even more concern was the finding 
that residents improved little with time and training and were never better than third-
year medical students. A multi-centre study, testing medical students, trainees, 
physicians and teaching faculty, more comprehensively, demonstrated low specificity 
for systolic murmurs (0.35) and low sensitivity for diastolic murmurs (0.49). (9) 
Paediatric residents fared somewhat better when tested on patients with a variety of 
cardiac diagnoses. (28) Although the overall accuracy rate was only 30%, there was an 
improvement with experience, and the ability to identify an innocent murmur was 84% 
in the more experienced residents. These studies have led to wide-spread concerns 
regarding the waning art of auscultation and the need for more directed teaching of 
cardiopulmonary auscultation. Several models have been proposed, from using heart 
sounds simulator laboratories and repetition to the creation of an auscultation’s 
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inability to play back or store heart sounds and transmit sounds to multiple listeners is 
a major barrier to effective teaching and training in auscultation. (7) The ability of a 
digital stethoscope to record sounds, replay them at different speeds, provide a visual 
display, and develop a database of heart sounds for ongoing teaching creates a unique 
and invaluable platform for teaching auscultation.  
3.6 Referrals for structural heart disease 
 
Although AHA/ACC only recommend that patients with suspected pathological 
murmurs be referred for an echo, (31) patients are still routinely referred to a specialist 
cardiac unit for echocardiography for the evaluation of a murmur.  In a retrospective 
review of 3 460 adult referrals for an echocardiogram with the coding ‘murmur’ as the 
primary reason for the referral, less than 50% had significant valvular disease. (32) 
Despite a higher percentage of female referrals (61.8% vs. 38.2% males), the 
percentage of abnormal valves in females w s even lower than in males (45.6% vs. 
53.5%).  
In another study, approximately two thirds of patients referred to a cardiac centre for 
initial evaluation of heart murmurs had no cardiac abnormalities. (33) In paediatrics, 
although heart murmurs are the most common reason for referral to cardiologists, 50% 
to 70% of these murmurs are benign. (34) The usefulness of a device to aid diagnostic 
accuracy of referring physicians in determining pathological murmurs cannot be over-
emphasized.  
3.7 Portable echocardiography versus auscultation 
 
Recently, portable echo machines have been proven to have superior sensitivity when 
compared to the mechanical stethoscope in screening for valvular heart disease in 
asymptomatic children. (35) The yield by portable echocardiography is 10 times greater 
than the mechanical stethoscope, leading to the recommendation to abandon the 
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echocardiography machines and the need for trained echocardiographers hamper the 
adoption of this screening modality on a large scale in poor developing countries where 
valvular heart disease remains endemic. It is therefore mandatory to explore other 
simple, sensitive, accessible, and affordable technologies. 
3.8 Digital stethoscopes: development and properties 
 
The pursuit of a quantitative and objective stethoscope has plagued investigators for 
decades, and electronic stethoscopes have been available commercially for some time. 
(36) Early criticisms related to ease of use, distortion of sound, even creating 
artefactual sounds, and cumbersome designs. However, over the past decade rapid 
advances have been made not only in the electronic stethoscopes themselves, but also 
in the spectral and velocity analyses and automated diagnosis algorithms. (10) The 
addition of auscultation analysis software has now created vast new opportunities. 
Computer-assisted Auscultation (CAA) is now able to conduct a spectral and temporal 
analysis of heart sounds, graphically display energy profiles relating to systolic and 
diastolic murmurs and formulate a conclusion, relating findings probabilistically to 
ACC/AHA Class I referral guidelines (37), while  providing better sound quality and  
visual display of the sounds’ wave form. (10) The quantitative measurement of the 
intensity of the heart sounds and murmurs in the spectral display, which is recorded 
simultaneously with the waveform of the sounds, allows objective classification into 
normal and abnormal sounds. (38) Signals obtained electronically may be subjected to 
objective visual and numerical analysis, transmission to distant sites, and storage for 
medical and research purposes. Although a similar model for pulmonary auscultation 
does not exist commercially, several instruments are in development (39), and studies 
are underway to develop appropriate clinical applications. (40) 
Of particular importance in developing countries is the cost, time and human resource 
saving associated with the use of a digital stethoscope. The digital stethoscope and 
associated software are a fraction of the cost of a echocardiography machine, as well as 
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cardiologist, and they can be used by nurses or other community health workers on all 
patients.  
 
Zargis ® Medical Corporation has Food and Drug Administration (FDA) clearance for the 
first product with clinically validated indications for uses including the detection of 
heart murmurs as a physicians’ aid. Sensitivity for detection of murmurs increased from 
77 % to 89 % with the use of Computer-Assisted Auscultation (CAA), while the referral 
sensitivity increased from 87 % to 93 %. (41) A South African company recently 
published findings of a decision support system aimed at the paediatric population. A 
specificity of 94% and a sensitivity of 91% was achieved using novel signal processing 
techniques and an ensemble of neural networks as classifier. (42)(43) 
3.9 Clinical opportunities  
 
Clinical applications of computer-assisted auscultation have thus far been exceedingly 
promising in terms of diagnostic decision support, inexpensive screening, and referral 
decision support. Primary care physicians were able to increase the sensitivity of 
murmurs detected with the use of CAA from 77% to 89 %, while referral sensitivity 
increased from 87 % to 93 %, and specificity increased from 64 % to 79 %. (41) The 
need for a cost-effective screening method to detect athletes at risk of sudden cardiac 
death due to Hypertrophic Cardiomyopathy (HCM) led to a pilot study examining the 
level of agreement between auscultatory findings by a cardiologist and the results of 
CAA. (44) This study was able to identify apical systolic murmurs that are louder in 
standing than in reclining positions: a cardinal sign of HCM. 
Acoustic cardiography is a related technique that records simultaneous digital ECG and 
heart sounds data, using dual-purpose ECG and heart sounds sensors rather than a 
digital stethoscope, while providing a computerised interpretation of the findings. An 
exploratory study determined that the use of this technology improved detection of 
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able to demonstrate that acoustic cardiography provides similar results, but with 
improved reproducibility and ease of use to echocardiography in the optimisation of 
cardiac resynchronization therapy. (46) 
3.10 Opportunities for future research 
 
The potential clinical utility of the digital stethoscope and associated software is 
tremendous, and its use in detecting cardiac disease is very exciting. Heart failure 
currently affects over 5 million people in the United States. The presence of S3 and S4 
heart sounds is an early abnormality in affected patients, yet notoriously difficult to 
hear and frequently missed. However, these sounds may be detected by CAA. (47) In 
fact, acoustic cardiography has been demonstrated (48) to outperform B-Natiuretic 
Peptide (BNP) alone at detecting reduced left ventricular ejection fraction. The most 
common cause of acquired heart disease in the world, Rheumatic Heart Disease (RHD), 
has long been neglected due to its waning incidence in the developed world. (49) A 
landmark study in Mozambique and Cambodia, however, demonstrated the under-
appreciation of affected patients by using portable echocardiography. (35) Wider 
application of this screening protocol using CAA may well be the simpler and more 
cost-effective way to screen for RHD in resource-poor settings. Preliminary work in this 
area is currently underway. (50) 
4. Challenges and further development 
 
Despite the remarkable potential of CAA, it has yet to be adopted into mainstream 
clinical practise by practitioners. Becket Mahnke (51) eloquently outlines some of the 
underlying reasons and identifies some key points. Firstly, it is vital that successful CAA 
systems have a clearly defined intended use, either screening or diagnostic. In addition, 
ease of use by minimally trained personnel in a primary care setting is of particular 
importance. Data must be analysed in real-time and be able to be stored in a format 
which can be integrated into clinical records. From a technical standpoint, standardized 
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a single-site CAA approach does not approximate the clinical routine of auscultation in 
different sites, use of diaphragm, bell and adjunct manoeuvres to comprehensively 
examine the heart and lungs. 
 
 This may well be achieved by use of a new recording device (Signal®, Zargis Medical, 
New Jersey) which allows for simultaneous acquisition of 6 auscultatory sites along 
with a single channel ECG and a plethysmography waveform. Work is currently 
underway to use this system for signal analysis. Close collaboration between engineers, 
clinicians and industry partners will be required to produce a CAA system which can 
truly become an important cardiac screening and diagnostic tool. 
5. Conclusion  
 
Heart disease is a major cause of morbidity and mortality throughout all age groups 
worldwide. For decades, the stethoscope and standard auscultation has been the first 
screening, diagnostic and prognostic tool utilised by health care providers.  However, 
the inherent limitations of the standard stethoscope, coupled with decreasing clinical 
competence in its use, has resulted in ever-declining reliance in auscultatory findings, 
increasing referrals, and use of more expensive technologies when not clinically 
indicated. Computer-assisted Auscultation (CAA) provides improved objectivity to a 
traditionally subjective, increasingly difficult clinical skill. A diagnostic support tool that 
could increase sensitivity and specificity of the echocardiography referral decisions 
could potentially be highly cost-effective, facilitate a more efficient use of personnel 
and resources, and may indeed be the promising technology required to improve the 
referral decisions of primary care physicians. 
Incorporating CAA into clinical practice could potentially allow for appropriate 
additional information in terms of structural heart disease and may well serve as a 
clinician’s tool, allowing for easier diagnosis especially in resource-poor settings. In 
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ability to store audio files in patients’ records, and in providing a new platform for 
teaching and training. The greatest value, perhaps, is the possibility of providing 
objective, reliable findings that are readily interpretable by practicing primary care 
clinicians to facilitate appropriate referrals to tertiary services. 
[Word count: 3334] 
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Abstract: 
Background: Cardiac auscultation is inherently qualitative, highly subjective and 
requires considerable skill and experience. Computer-assisted auscultation (CAA) is an 
objective referral-decision support tool that aims to minimise inappropriate referrals. 
This study evaluated the sensitivity and specificity of 2 computer-assisted auscultation 
systems in detecting echo-confirmed cardiac abnormalities. 
Methods: There were 79 consecutive patients referred for assessment to a tertiary 
cardiac clinic recruited into the study. Participants underwent an examination using 
computer-assisted auscultation (CAA) methods in addition to the standard clinical 
examination and echocardiogram. 
Results: The prevalence of echocardiography-confirmed structural heart disease was 
53% (n= 42). The CAA systems were able to complete the recordings in virtually all the 
cases. The overall sensitivity of Cardioscan® to identify cardiac abnormalities in children 
was 92% [71-99%] and 60% [41-77%] in adults while the specificity was 47% [21-73%] 
and 67% [30-93%] in children and adults respectively. The sensitivity of the Sensi® 
system in identifying cardiac abnormalities in children was 79% [45-93%] and 84% [61-
97%] in adults while the specificity was 57% [29-82%] and 67% [30-93%] in children and 
adults respectively. In subgroup analysis, the sensitivity for detecting acyanotic heart 
disease was 100% using both Cardioscan® and Sensi®.  
Conclusion: Computer-assisted auscultation demonstrates suboptimal sensitivity and 
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demonstrate 100% sensitivity in detecting acyanotic heart disease, and theoretically 
carries significant potential in resource-limited settings, further development of current 
technologies to improve sensitivity and specificity for clinical applications is still 
warranted.  
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Cardiac auscultation is inherently qualitative, highly subjective and requires 
considerable skill and experience. The decline in teaching of auscultation and poor 
accuracy at diagnosing heart sounds and murmurs has resulted in a reduced ability to 
discern an innocent murmur from one suggestive of pathology.  The current 
recommendation is that only patients with suspected pathological murmurs be 
referred for an echocardiogram. In resource-limited settings, a simple screening tool to 
identify the need for referral for further evaluation is urgently needed.  A referral 
decision support tool that could increase sensitivity and specificity of echocardiography 
referral decisions could be the promising technology required to improve the referral 




In the hands of skilled practitioners, cardiac auscultation is an indispensible diagnostic 
aid allowing clinicians to diagnose cardiac disease consistently and accurately. (1) 
Cardiac auscultation serves two important purposes, namely firstly as a screening tool 
(disease yes/no, requires referral yes/no) and secondly as a cardiac diagnostic tool 
(disease type and severity). Both these functions can be performed with a high degree 
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importance of the first function, i.e. as a screening tool to differentiate through 
auscultation whether a patient has cardiac disease and requires referral, should not be 
over-estimated in the primary health care setting.  However, the task of primary care 
physicians of screening for cardiac disease is made more difficult by the fact that the 
probability of cardiac disease is low (<1 %). Yet, heart murmurs are very common in the 
general public, particularly in children, even though most have no clinical relevance. (3) 
Up to 80% of paediatric patients will have a murmur on examination although less than 
1% will eventually have a congenital heart defect.(4) Precordial murmurs are also 
common in young adults, occurring in between 29-52% of the general population. (5)  
 
Echocardiography is considered to be the gold standard to determine pathological 
cardiac lesions. However the American Heart Association and the American College of 
Cardiology defines Class 1 recommendations for echocardiography as those patients 
where “clinical features indicate at least a moderate probability that a murmur reflects 
structural heart disease.” (6) The American Heart Association and the American College 
of Cardiology guidelines strongly discourage indiscriminate use of echocardiography as 
a screening tool due to the significant cost and the over-sensitive nature of the results. 
Despite this, patients are still routinely referred to a specialist cardiac unit for 
echocardiography for the evaluation of a murmur.  In one retrospective review of 3 460 
adult referrals for echocardiogram with the coding ”murmur” as the primary reason for 
the referral in a University Medical Centre in California, less than 50% had significant 
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The ability to accurately screen for cardiac disease is extremely important in sub-
Saharan Africa and other resource-poor settings. The developing world is currently 
facing a “double burden of disease’ the significant infectious disease agenda and the 
emerging agenda of non-communicable diseases in particular cardiovascular diseases. 
(8, 9) Cardiovascular disease can be diagnosed in its initial stages facilitating early 
initiation of therapy while congenital cardiac lesions can be detected early enough to 
avoid irreversible physiological consequences. In 2009 South Africa had 24 practicing 
paediatric cardiologists, equally distributed between public and private sector units. 
(10) This is woefully inadequate for the needs of the country’s 18.7 million children and 
significantly less than the 88 paediatric cardiologists required for the population of 
South Africa. (11)  Although paediatric cardiologists can accurately diagnose an 
innocent murmur with a high degree of sensitivity and specificity (12), a referral to a 
paediatric cardiologist for an innocent murmur implies inappropriate use of skilled and 
scarce personnel as well as a not insignificant social and economic cost. In South Africa 
and other settings, an accurate cardiac screening tool to identify patients requiring 
referral for echocardiography has tremendous potential to improve the quality of 
health care services and reduce costly and unnecessary referrals. Such a tool would 
need to be highly specific and likelihood ratios should be used in conjunction with pre-
test probabilities to provide post-test probabilities of disease. 
 
The goal of this study was to evaluate the sensitivity and in particular, the specificity of 
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for suspected cardiac disease when compared to echocardiography. Attention was also 





Over the past decade rapid advances have been made in extending digital auscultation 
by using spectral and velocity analyses and automated diagnosis algorithms. (13) 
Computer-assisted auscultation (CAA) is now able to conduct a spectral and temporal 
analysis of heart sounds, graphically display energy profiles relating to systolic and 
diastolic murmurs and formulate a conclusion relating findings to the American Heart 
Association and the American College of Cardiology class I referral guidelines while 
providing better sound quality and visual display of the sounds’ wave form. (13, 14) The 
quantitative measurement of the intensity of the heart sounds and murmurs in the 
spectral display, which is recorded simultaneously with the waveform of the sounds, 
allows objective classification into normal and abnormal sounds. (15) It has been 
demonstrated that artificial neural networks used in the pattern recognition and 
classification tasks associated with automated heart sounds analysis is able to achieve 
sensitivities and specificities of 100% when heart sound samples from selected patients 
were processed and then fed into a custom artificial neural network using a spectral 
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Zargis ® Medical Corporation was the first product with clinically validated indications 
for use by physicians including the detection of heart murmurs. Sensitivity for detection 
of murmurs increased from 77% to 89% with the use of the Cardioscan® software while 
the referral sensitivity increased from 87% to 93%. Primary care physicians were able to 
decrease their average false positive referral rate from 37% to 21% (p<0.001) while 
reducing their false negative rates from 13% to 7%.  (17) A South African company 
recently published findings of their decision support system aimed at the paediatric 
population. A specificity of 94% and a sensitivity of 91% were achieved using novel 
signal processing techniques and an ensemble of neural networks as classifier. (18) (19) 
A referral decision support tool such as CAA could potentially be highly cost-effective 





We conducted a cross-sectional screening study among patients referred to Groote 
Schuur or Red Cross War Memorial Children’s Hospital. These are 2 of the 3 major 
referral hospitals in the Western Cape. These referrals are from physicians, 
paediatricians or primary health care practitioners. Seventy-nine consecutive patients 
referred either assessment of possible heart disease, follow-up of known heart disease 
or cardiac evaluation in the setting of other diseases were recruited for the study 










 Submission: dissertation for MPH [Clinical Research Methods] HNDLIE001 
67 | P a g e  
 
 The University of Cape Town Human Research Ethics Committee reviewed and 
approved the protocol (HREC Ref No 359/10).  
 
Consented participants underwent the standard examination including in each case, an 
echocardiogram and clinical examination followed by an examination using both of the 
computer-assisted auscultation methods. Neither the physician nor the 
echocardiographer was aware of the findings of the digital recordings. 
Echocardiograms were deemed normal if no diagnosis other than physiological 
pulmonary and tricuspid regurgitation was made. All studies with structural heart 
disease were deemed abnormal. All echocardiograms were performed by trained 
echocardiographers.  
 
With the Cardioscan® system, the patient was auscultated using a Littman® Bluetooth 
electronic stethoscope. The heart sounds were recorded at the 4 standard positions for 
20 seconds each. The Cardioscan ®software analysed the recording for up to one 
minute and then displayed the findings as abnormal or normal.  Prior to auscultation 
using the Sensi® system, 3 ECG electrodes were placed upon the chest. Following this, 
recordings were made at the same four precordial positions using the Welch-Allen 
stethoscope®. All recordings were performed in the supine position and in a quiet 
environment. Prior to commencing the study, extensive training was undertaken and 
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Quality assurance was maintained throughout and equipment was checked at several 
intervals throughout the study. 
 Data were analysed using STATA® version 11, Texas, USA. The sample size of 79 
patients was calculated to achieve <10% confidence intervals around an estimated 
sensitivity of 90% for either computer-assisted stethoscope.  In the analysis, we 
calculated the sensitivity and specificity of the different CAA systems to detect 
abnormalities on echocardiogram and likelihood ratios for discrimination between 
benign and pathologic cases. Results were stratified by participant age (children versus 
adults) and pathological categories. The Mantel-Haenszel Test for heterogeneity was 
performed to examine the performance of the tests varied by age strata. All statistical 
tests were 2-sided at alpha=0.05. Repeat an lyses were performed after excluding 
participants where the recordings were deemed reasonable (i.e. recordings completed 
with minor difficulties) as well after excluding any participants with heart rates over 
120/min. The McNemars Test of significance was used to assess the difference 




In total, consecutive 79 participants were recruited, 40 children and 39 adults (Table 1). 
The median age among children was 3 years (IQR, 1-7 years) and 46 years (IQR, 32 to 
62 years) in adults. Slightly more than half of participants were female. Participants 
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confirmed prevalence of structural heart disease was 52% (n= 41, median age 9 
years,IQR, 2-41 years)  There were 24 participants without heart disease (30% of the 
total) and 14 (18%) patients diagnosed with a cardiac abnormality other than structural 
cardiac disease. These included cardiomyopathies (n=5), left ventricular dysfunction 
(n=5), pericardial effusion (n=1) and pulmonary hypertension (n=3).  
 
Overall, the Cardioscan® system was able to complete the computer assisted 
auscultation recordings in 98% of participants (95% of children and 100% of adults) 
while the Sensi® system completed the recordings in 95% of participants (93% of 
children and 97% of adults). The quality of the Cardioscan® recordings was deemed 
excellent in 73 cases (92%), in 4 (5%) cases problems were encountered although the 
procedure was completed while in 2 (3%) recordings, the recording procedures could 
not be completed. The Sensi® recordings were incomplete in 4 cases (5%), there were 
recoding difficulties with 7 participants (9%) and the quality deemed excellent in 68 
cases (86%). 
 
The sensitivity of the Cardioscan® system in identifying heart disease on 
echocardiography in children was 92% [73-99%] (Table 3). The specificity was 47% [21-
73%] with a positive likelihood ratio test of 1.8 and a negative likelihood ratio test of 
0.6. In adults the sensitivity was 60% [41%-77%], the specificity was 67% [30%-93%], 
the positive likelihood ratio was 2 and the negative likelihood ratio was 0.2. The Sensi® 
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negative likelihood ratio of 0.4 in children and 0.2 in adults respectively. The 
sensitivities for children were 78% [56-93%] and for adults were 84% [60-97%]. The 
percentage correctly classified was 75% and 61% by Cardioscan® and 70% and 58% by 
Sensi® in children and adults respectively. The overall likelihood ratios for the test 
performance were significantly better in children compared to adults for both 
Cardioscan® [p=0.006] and Sensi® [p=0.02].There was no significant difference 
demonstrated when comparing sensitivities and specificities achieved by both systems 
in adults, however Cardioscan® did demonstrate significantly improved sensitivity in 
children than in adults.[McNemar’s chi-square p<0.001] 
 
Table 4 shows the performance characteristics of the 2 systems having excluded 
recordings with any problems and children with heart rates over 120 during recording.  
Although sensitivities increase marginally using both systems, there is a decrease in 
specificity demonstrated by Cardioscan®. In the analysis, the overall likelihood ratios 
for the test performance remains significantly better in children compared to adults for 
both Cardioscan® [p=0.006] and Sensi® [p=0.02] (Table 4) 
 
A sub-analysis reviewed the findings in terms of the classification of cardiac disease 
(Table 5), prior to excluding poor quality recordings.  The specificity to detect normal 
cases was low using both Cardioscan® and Sensi®. Cardioscan® was 54% [33-74%] and 
Sensi® was 61% [39-80]. However the sensitivity to detect acyanotic heart disease was 
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cyanotic heart lesions was 100% using the Sensi® system and only 75% using the 
Cardioscan® software. Sensitivities to detect abnormalities in cases with valvular 




Computer-assisted auscultation is potentially a tool to screen for cardiovascular disease 
in particular at the primary health care level. This study sought to evaluate 2 available 
systems to detect cardiac disease in patients presenting for assessment at a cardiac 
clinic. Despite many theoretical advantages, neither system was able to demonstrate 
sufficiently high sensitivities or specificities in screening for cardiac disease in this 
population. 
 
This is the first study evaluating the use of CAA to distinguish normal from pathologic 
cases in a cardiac clinic in a developing country setting. Although 2 previous studies of 
CAA were performed in South Africa, both of these related to development of an 
autonomous auscultation system and artificial neural networks. (19, 20) This study also 
represents the real-world situation in busy referral centres and reflects the pathology 
referred to cardiac clinics on a daily basis. 
 
These data suggested a suboptimal sensitivity and specificity and likelihood ratio test 
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in the sub- analysis of the cases with no demonstrated heart disease where both 
systems demonstrated a specificity of below 60% and consequently high percentage of 
false positives.  
 
CAA has yet to make an impact of routine cardiovascular assessment. To be clinically 
acceptable, a high sensitivity and specificity must be achieved both when used as a 
referral decision tool and when quantifying the severity of lesions. The complexity of 
the signal processing involved as well as the inherent differences across populations 
and pathophysiological mechanisms of cardiovascular disease has delayed the 
introduction of CAA into clinical care.  
 
Both systems have previously demonstrated excellent sensitivities and specificities in 
preliminary evaluations (9, 21, 22), and there are several possible reasons for the 
relatively poor performance demonstrated here. This study represents a lower median 
age.  It is also important to be aware of the physiological differences in children, in that 
even innocent murmurs are able to be conducted easily through the chest wall using 
very sensitive stethoscopes such as these electronic stethoscopes. In addition the 
Zargis software was designed not to be accurate in patients with a heart rate above 120 
per minute. 
 
The 2 systems have a different auscultation order and reversing the order of 
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operating procedures together with repeated quality control was upheld throughout 
the study. The quality of recordings was deemed adequate if the auscultation sequence 
could be completed, this was not however verified with additional testing. Finally the 
Cardioscan® system made use of a Bluetooth® dongle which was left in the computer 
while simultaneously connecting to the Sensi ®system using another USB port. It is 
however unlikely that this could have affected the results of the Sensi system. 
 
It has been suggested that the incorporation of other sensor modalities can provide 
important additional data which can also be utilised for further corroboration of 
conflicting results. (23) In our study, we auscultated at 4 sites and with the Sensi® 
system had the additional ECG electrodes to ensure correct partitioning of heart 
sounds, however still demonstrated poor accuracy. In addition, although this was only 
applicable to 1 of our adult cases, CAA in the cardiovascular examination of the 
morbidly obese has been shown not to be of assistance.(24) 
 
Currently, algorithms for computer analysis have no uniformity or standardization 
resulting in a variety of end points and uses. Some algorithms have specifically 
designed to detect pathologic systolic murmurs only, (22), despite the fact that most 
diastolic murmurs are associated with pathology. In addition algorithms do not take 
into account the fact that important cardiac diseases for which screening would be of 
use, such as cardiac failure, may not have any murmurs but instead present with 
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cases presented without a murmur or only a grade 1 or 2 systolic murmur yet was 
diagnosed on echocardiogram with cardiac disease. To date, only experimental models 
exist to detect third heart sounds.(25)  
 
This study had several strengths. It is the first study attempting to determine the role of 
2 CAA systems in evaluating the presence of disease in patients presenting to a cardiac 
clinic for assessment or evaluation for cardiac disease. Cases with a wide range of 
cardiac pathologies and age ranges (minimum 2 months, maximum 79 years) were 
enrolled in order to approximate the typical patient population referred to these 
cardiac clinics. Although there was an expectedly high prevalence of disease, 30% of 
patients referred were found to have no cardiac lesions. We used clinical cases 
purposely as opposed to pre-recorded or digitized sound recordings. The patient 
population reflects the referral patterns from primary or secondary health facilities and 
thus achieves generalisability to settings with limited cardiology at primary care level. 
We were also able to enrol a large enough sample to power the study to determine the 
appropriate performance characteristics. 
 
This study was designed to look at the function of CAA systems in referral decision 
support and therefore the comparative gold standard was the echocardiogram. It may 
have been of added worth to correlate the findings with standard auscultation to 
determine the presence of additional heart sounds or clicks. However detailed findings 
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single physician. Although we attempted to obtain a wide range of pathologies and 
ages, the mean age of the entire sample was 9 years which may be more 
representative of the paediatric population. This study was neither powered for 
numbers of adults and children, nor for all pathologic strata. Thus as the sample was 
not stratified according to pathologies, some pathologies such as the cardiomyopathies 
are under-represented.  
 
Screening for heart disease using auscultation is a vital part of general paediatrics and 
family medicine and fulfils an important role in preoperative assessment and pre-
screening for participation in athletics (26) (27). The essence of screening is detecting 
abnormalities requiring further cardiac evalu tion. A referral decision support tool 
would facilitate this decision and provide much needed support for primary care staff 
away from more equipped centres. The ever-increasing need for skilled health care 
workers especially in low and middle income countries has led to the formation of a 
lesser trained cadres of assistant medical officers, community health workers and task 
shifting. (28) The use of technological advances to aid in this process can be invaluable 
and research in this area has demonstrated the potential benefits of technological aids. 
For example, the use of a referral support algorithm on hand-held PDA’s (personal 
digital assistants) for community health care workers provided safe and effective 
community-based care to HIV-infected cases in Western Kenya and demonstrate the 
role of technology to expand the capacity of health care institutions in resource-
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for cardiac disease and support referral decisions especially from resource-poor 
settings is urgently needed. 
 
In conclusion, CAA has the potential to extend the role of auscultation and improve the 
quantitative nature of a difficult skill. Currently there are neither standardized digital 
stethoscopes nor algorithms commercially available. We evaluated 2 systems currently 
available and were not able to demonstrate a sufficiently high sensitivity or specificity 
to justify their introduction into routine clinical medicine. That said, the promise that 
CAA could make a valuable contribution to clinical medicine in particular in the area of 
aiding with referral decision support for primary care practitioners suggests that 
further refinements and testing is warranted and should be encouraged and supported 
by clinicians.   
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Table 1. Patient Characteristics
Children Adults Total
No. 40 39 79
Age in years,  med (IQR) 3(1-7) 46(32-62) 9(3-46)
Sex(M:F) 1: 1.1 1:1.4 1:1.3
Outpatient referrals 33 20 53
Ward referrals 7 19 26
Children Adults Total
n % n % n %
Normal 15 38 9 23 24 29
16 40 2 5 18 24
4 10 0 4 5
1 3 18 46 19 24
Cardiomyopthies e.g. DCM, HCM 3 8 2 5 5 6
Other: Hypertension 0 0 3 8 3 4
Left ventricular Failure 0 0 2 5 2 3
Pulkmonary Hypertension 1 3 2 5 3 4
Pericardial Effussion 0 0 1 3 1 1
Total: 79 100
Children ACC/AHA murmur referral class No of patients (%)
n %
Normal heart sounds, no murmur NA 6 15
Grade 1/6, systolic ejection murmur III 6 15
Grade 2/6, systolic ejection murmur III 4 10
Grade 3/6, midsystolic murmur I 12 31
Grade 2/6, halosystolic murmur I 10 26
Grade 2/6, diastolic murmur I 0 0
Grade 2/6, continuous murmur I 1 3
Total: 39 100
Adults ACC/AHA murmur referral class No of patients (%)
n %
Normal heart sounds, no murmur NA 15 47
Grade 1/6, systolic ejection murmur III 0 0
Grade 2/6, systolic ejection murmur III 1 3
Grade 3/6, midsystolic murmur I 4 13
Grade 2/6, halosystolic murmur I 7 22
Grade 2/6, diastolic murmur I 5 16
Grade 2/6, continuous murmur I 0 0
Total: 32 100
 Cardiac Diagnoses as determined by echocardiography
Acyanotic congenital heart lesions e.g. ASD, VSD, PDA
Cyanotic congenital heart lesions e.g. TOF, UVH
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Not completed 2 0
40 39
Sensi ® confidence mean(±SD) 90(±5) 87(±7)
Sensi ®Quality Excellent 35(88%) Excellent 37(95%)
Reasonable 3(8%) Reasonable 1(2.5%)
Bad 2(4%) Bad 1(2.5%)
Zargis ®Quality Excellent 731(78%) Excellent 38(97%)
reasonable 6(15%) reasonable 1(3%)
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  Children n=39   Adults n=39   Both n=78 Children n=37 Adults n=38 Both n=75 
  








































































































p values(M-H test for 
heterogeneity) 
    
p=0.02 
     
p=0.006 
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Table 4 . Performance Characteristics of Both Systems  excluding poor quality recordings
Cardioscan® Sensi ®
Children n=27 Adults n=36 Both n=64 Children n=28 Adults n=36 Both n=64
Sensitivity 94%[73-99%] 55%[41-77%] 70%[55-83%] 82%[56-96%] 59%[39-78%] 68%[52-81%]
Specificity 56%[23-83%] 67%[30-93%] 60%[36-81%] 55%[30-82%] 67%[30-93%] 60%[36-81%]
LR+ 2.1 1.7 1.7 1.8 1.8 1.7
LR- 0.1 0.7 0.5 0.3 0.6 0.5
LR test 21 2.4 3.2 6 3 3.4
OR 19[2-936] 3[0.4-18] 4[1-13] 6[0.8-46] 3[0.4-21] 3[0.9-11]
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61%[39-80%] 
  
       
  
Acyanotic Congenital Heart Lesions n=17 100% 





       
  
Cyanotic Congenital Heart Lesions n=4 75% 





       
  
Valvular Lesions n=19 74% 





       
  
Cardiomyopathies n=5 60% 





       
  
Other n=9 33% 
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reserves copyright and renewal on all published material, and such material may not be reproduced 
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all authors; (2) abstract; (3) text; (4) acknowledgement; (5) references; (6) figure legends; ; (7) tables; 
and (8) figures. Number the title page as 1, abstract page as 2 and so forth. Type double-spaced 
(including references) with at least 25-mm (1-inch) margins, sized for 8.5 x 11 inch paper. Place 2 
returns after every element, such as title, headings, paragraphs, figure captions, etc. Files should be 
labeled with appropriate and descriptive file names. Upload text, tables and graphics as separate files. 
Do not import figures or tables into the text document. Complete instructions for electronic artwork 
submission can be found on the Author Gateway, accessible through the journal home page. 
TITLE PAGE AND ABSTRACT: For the complete title page, include the full first or middle and 
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Limit the abstract to 250 words. 
List 2 to 4 key words for subject indexing at the end of the abstract. 
STYLE: Use appropriate major subheadings throughout the body of the text, such as Methods, 
Results, and Discussion. Tables, 
figures, and references must be cited in numerical order throughout the manuscript. 
Abbreviations are permitted, 
but usually no more than 5 per manuscript (at the Editor's discretion) , and then they must be used on 
every page of the manuscript after 
they are initially spelled out (followed by the abbreviation) in both abstract and introduction. 
Abbreviations are usually limited to terms in the manuscript's title. Use generic names of drugs. Do 
not spell out any number, including those less than 10, except when used for opening a sentence, but 
try not to begin sentences with a number. Use symbols for less than (<), greater than (>) and percent 
(%). Indent paragraphs except for the first one in both abstract and introduction. Consult the Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals, published in The Annals of Internal 
Medicine June 1982;96:766-771, and also the Stylebook/Editorial Manual of the AMA. 
References: List all authors, year, volume, and inclusive pages for all journal references, and specific 
page numbers for all book 
references as shown below. Do not use periods after authors' initials or after abbreviations for titles of 
journals. Check Index Medicus or 
Annals of Internal Medicine (June 1982) as cited above for journal titles and abbreviations. Personal 
communications and unpublished 
observations do not constitute references, but may be mentioned within the text. Articles with 
incorrect reference formats will not be 
processed. Do not use "et al" - names of all authors must be included. All references must be typed out 
at the end of the article on a new page. Please do not use the footnote or endnote functions in your 
word processing program. 
Journal: Harvey W, Herberden W, Withering W, Stokes W, Murrell W, Einthoven W, Osler W. 
Anomalies and curiosities of cardiology and cardiologists. Reflections of famous medical Williams. 
Am J Cardiol 1984;53:900-915. 
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RS S Feeds 
Art Chapter in Book: Cabot RC, White PD, Taussig HB, Levine SA, Wood P, Friedberg CK, Nadas 
AS, Hurst JW, Braunwald E. How to write cardiology textbooks. In: Hope JA, ed. A Treatise on 
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only. They are not acceptable for publication. Do not import figures into the text document. Complete 
instructions for electronic artwork submission can be found on the Author Gateway, accessible 
through the journal home page. Submit written permission from the publisher and author to reproduce 
any previously published figures. Limit figures to the number necessary to present the message 
clearly. 
Figure resolution must be a minimum of 300 dpi. Type figure legends on a separate page, double 
spaced after the references. Identify at the end of each legend and in alphabetical order all 
abbreviations in the figure. The cost of color reproduction must be paid by the author. 
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each table as a separate file. 
Identify in alphabetical order at the bottom of the table all abbreviations used. When tabulating 
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available" or "not done." Do not use "yes", "no" or "none." 
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